Safe use of streptokinase in myocardial infarction in patients aged 75 and over.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1480538.
- Also identified by PMC identifier 2399444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have given streptokinase to 73 patients aged 75 and over admitted to medical admission wards for elderly people using strict exclusion criteria. This was safe and free from significant adverse events by comparison with other studies. The average age of the patients was 78.2 years so they formed a relatively young group compared with all patients over 75. There was a relatively long delay between presentation at the hospital and receipt of treatment.
Medical subject headings
- Myocardial Infarction
- Streptokinase
- Thrombolytic Therapy